President and CEO, Mountain View Eye Center, PC
Ophthalmology
Robert L. Treft, MD works in the field of Ophthalmology. He went to medical school at University of Utah School of Medicine. He received 3 awards: "Recipient", "Fellow (FAAO)" and "Fellow (FACS)". Robert Treft has written publications. He has 1 publication published with PubMed. The lastest publication is: 'Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmoplegia: a syndrome caused by a missense mutation in OPA1.' Robert L. Treft, MD accepts all Medicare patients.
Publications
Schools
University of Utah
Lds Hospital
Procedures Preformed
- Anterior Vitrectomy
- Blepharoplasty
- Canthoplasty and Canthopexy
- Cataract Removal Surgery
- View All
Conditions Treated
- Age-Related Macular Degeneration
- Aphakia and Other Disorders of Lens
- Astigmatism
- Bell's Palsy
- View All
Doctors Specialties
Accepted Insurances
- Choice Plus POS II
- Altius Health Plans
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- GEHA
- Humana
- Mail Handlers Benefit Plan (MHBP)
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Heritage Signature
- SelectHealth
- Choice Plus POS
- Options PPO
- United Healthcare
- Wisconsin Physicians Service
Awards
- Recipient
- Fellow (FAAO)
- Fellow (FACS)
Education
-
University of Utah
-
University of Utah School of Medicine
Drug Facts
NPI NUMBER |
|
1851361539 |
NPPES Provider LastName |
|
TREFT |
NPPES Provider FirstName |
|
ROBERT |
NPPES Provider ZIPCode |
|
840411160 |
NPPES Provider State |
|
UT |
Specialty Description |
|
Ophthalmology |
Total Claim Count |
|
825.0 |
Distinct Opioid Count |
|
0.0 |
Opioid Claim Count |
|
0.0 |
Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1851361539 |
Last Name Of The Provider |
TREFT |
First Name Of The Provider |
ROBERT |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog